Segall Bryant & Hamill, LLC Chembio Diagnostics, Inc. Transaction History
Segall Bryant & Hamill, LLC
- $7.16 Billion
- Q3 2024
Shares
13 transactions
About CHEMBIO DIAGNOSTICS, INC.
- Ticker CEMI
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 30,224,600
- Description
- Chembio Diagnostics, Inc., together with its subsidiaries, develops, manufactures, and commercializes point-of-care (POC) diagnostic tests that are used to detect or diagnose diseases. The company offers tests for COVID-19, HIV and Syphilis, and Zika virus. It also develops tests for malaria, dengue, chikungunya, Chagas, ebola, leishmaniasis, la...